下一代测序 (NGS) 的诊断准确性,用于识别晚期非小细胞肺癌中可操作的突变:系统审查和元分析

相关实验视频

Updated: Jan 6, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

Nicolás Téllez Castillo1, Ana M Goyeneche-García2, Luisa M Montoya Quesada3

  • 1Faculty of Medicine, Department of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia. jnicolas.tellezc@javeriana.edu.co.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|September 13, 2025
PubMed
概括

下一代测序 (NGS) 显示了与标准测试相比的准确性,用于检测非小细胞肺癌中可操作的突变. 使用NGS的液体活检提供更快的结果,对特定突变有效,尽管基因重组检测需要改进.

关键词:
可以采取行动的突变.非小细胞肺癌的癌症诊断的准确性 诊断的准确性进行元分析和系统审查.下一代测序 (NGS) 是指下一代的测序.非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.

更多相关视频

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

305
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.9K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K